Actinium Pharma inks research pact with Memorial Sloan Kettering to support further clinical expansion of Actimab─A's ...
Actinium Pharmaceuticals, Inc., a pioneer in the development of targeted radiotherapies, announced it has entered into a sponsored research agreement with Memorial Sloan Kettering Cancer Center (MSKCC) to expand Actimab-A's mutation agnostic mechanism …